Differential Regulation of Bcl-xL Gene Expression by Corticosterone, Progesterone, and Retinoic Acid

被引:2
作者
Morrissy, Steve J. [1 ,2 ]
Sun, Haipeng [1 ,3 ]
Zhang, Jack [1 ]
Strom, Joshua [1 ]
Chen, Qin M. [1 ]
机构
[1] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA
[2] Univ Calif Davis, Dept Cardiol, 4860 Y St, Sacramento, CA 95817 USA
[3] Univ Calif Los Angeles, Div Mol Med, Dept Anesthesiol, CHS RM BH-569,650 Charles E Young Dr, Los Angeles, CA 90095 USA
关键词
Apoptosis; Cell Survival; Nuclear Receptor; Steroids; Retinoids; NF-KAPPA-B; BCL-X EXPRESSION; DEPENDENT INDUCTION; INDUCED APOPTOSIS; LIGAND-BINDING; HEART-FAILURE; CELL-DEATH; P38; MAPK; RECEPTOR; TRANSCRIPTION;
D O I
10.1002/jbt.21795
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Corticosterone (CT), progesterone (PG), and retinoic acid (RA) are capable of inhibiting Doxorubicin (Dox) from inducing apoptosis in rat cardiomyocytes. Mechanistically, CT, PG, and RA induce increases of Bcl-x(L) protein and mRNA, and activate a 3.2kb bcl-x gene promoter. CT and RA, but not PG, induced the activity of a 0.9kb bcl-x promoter, containing sequences for AP-1 and NF-kB binding. RA, but not CT or PG, induced NF-kB activation. CT, but not PG or RA, induced AP-1 activation, and induction of the 0.9kb bcl-x reporter by CT was inhibited by dominant negative c-Jun TAM-67 or removal of AP-1 binding site. Therefore, although CT, PG, and RA all induce Bcl-x(L) mRNA and protein, three independent mechanisms are in operation: while CT induces Bcl-x(L) via AP-1 transcription factor, and RA induces NF-kB activation and bcl-x promoter activity, PG induces Bcl-x(L) via a mechanism independent of NF-kB or AP-1.
引用
收藏
页码:309 / 316
页数:8
相关论文
共 50 条
  • [1] Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression
    Monsalve, D. M.
    Merced, T.
    Fernandez, I. F.
    Blanco, S.
    Vazquez-Cedeira, M.
    Lazo, P. A.
    CELL DEATH & DISEASE, 2013, 4 : e513 - e513
  • [2] Regulation of Bcl-xL expression in lung vascular smooth muscle
    Suzuki, Yuichiro J.
    Nagase, Hiroko
    Wong, Chi Ming
    Kumar, Shilpashree Vinod
    Lain, Vivek
    Park, Ah-Mee
    Day, Regina M.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2007, 36 (06) : 678 - 687
  • [3] Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma
    Yoshimine, S.
    Kikuchi, E.
    Kosaka, T.
    Mikami, S.
    Miyajima, A.
    Okada, Y.
    Oya, M.
    BRITISH JOURNAL OF CANCER, 2013, 108 (11) : 2312 - 2320
  • [4] Roles and Regulation of BCL-xL in Hematological Malignancies
    Morales-Martinez, Mario
    Vega, Mario I.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (04)
  • [5] Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression
    D M Monsalve
    T Merced
    I F Fernández
    S Blanco
    M Vázquez-Cedeira
    P A Lazo
    Cell Death & Disease, 2013, 4 : e513 - e513
  • [6] Bcl-xL expression in vivo in rheumatoid synovium
    S. Busteed
    M. W. Bennett
    C. Molloy
    A. Houston
    M. A. Stone
    F. Shanahan
    M. G. Molloy
    J. O’Connell
    Clinical Rheumatology, 2006, 25 : 789 - 793
  • [7] Bcl-xL expression in vivo in rheumatoid synovium
    Busteed, S.
    Bennett, M. W.
    Molloy, C.
    Houston, A.
    Stone, M. A.
    Shanahan, F.
    Molloy, M. G.
    O'Connell, J.
    CLINICAL RHEUMATOLOGY, 2006, 25 (06) : 789 - 793
  • [8] Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer
    Alam, Manzar
    Mishra, Rajakishore
    LIFE SCIENCES, 2021, 280
  • [9] A DIGE Approach for the Assessment of Differential Expression of the CHO Proteome Under Sodium Butyrate Addition: Effect of Bcl-xL Overexpression
    Baik, Jong Youn
    Lee, Gyun Min
    BIOTECHNOLOGY AND BIOENGINEERING, 2010, 105 (02) : 358 - 367
  • [10] I-BP inhibits NF-κB activity and Bcl-xL expression in astrocytes in vitro and reduces Bcl-xL expression in the brains of rats in vivo
    Yoshida, Y.
    Liu, J. Q.
    Nakano, Y.
    Ueno, S.
    Ohmori, S.
    Fueta, Y.
    Ishidao, T.
    Kunugita, N.
    Yamashita, U.
    Hori, H.
    NEUROTOXICOLOGY, 2007, 28 (02) : 381 - 386